We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 24.6%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+24.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$121M
AUM Growth
-$122M
Cap. Flow
-$128M
Cap. Flow %
-105.96%
Top 10 Hldgs %
3.37%
Holding
2,761
New
577
Increased
331
Reduced
1,242
Closed
547

Sector Composition

Rank Sector Weight
1 Industrials 15.08%
2 Financials 14.7%
3 Technology 12.2%
4 Healthcare 10.89%
5 Consumer Discretionary 10.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
1751
DELISTED
Global Blood Therapeutics, Inc.
GBT
$15K 0.01%
+394
New +$9.92K
PTR
1752
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$15K 0.01%
200
-700
-78% -$54K
JMP
1753
DELISTED
JMP Group LLC
JMP
$15K 0.01%
2,516
-3,135
-55% -$19.7K
KIN
1754
DELISTED
Kindred Biosciences, Inc.
KIN
$15K 0.01%
+2,181
New +$13.7K
ECYT
1755
DELISTED
Endocyte, Inc. Common Stock
ECYT
$15K 0.01%
5,735
-20,326
-78% -$47K
KS
1756
DELISTED
KapStone Paper and Pack Corp.
KS
$15K 0.01%
659
-3,800
-85% -$87.7K
EVBS
1757
DELISTED
Eastern Virginia Bankshares In
EVBS
$15K 0.01%
1,462
-6,321
-81% -$66.1K
MOCO
1758
DELISTED
Mocon Inc
MOCO
$15K 0.01%
683
-5,413
-89% -$109K
AV
1759
DELISTED
Aviva Plc
AV
$15K 0.01%
1,100
PACD
1760
DELISTED
Pacific Drilling S A
PACD
$15K 0.01%
6,593
-56,255
-90% -$177K
ATI icon
1761
ATI
ATI
$30.8B
$14K 0.01%
+807
New +$15.2K
CARM
1762
DELISTED
Carisma Therapeutics
CARM
$14K 0.01%
322
-2,349
-88% -$97.9K
CUBI icon
1763
Customers Bancorp
CUBI
$2.8B
$14K 0.01%
435
-499
-53% -$17K
CVV icon
1764
CVD Equipment Corp
CVV
$52.5M
$14K 0.01%
1,372
-7,576
-85% -$75.5K
DINO icon
1765
HF Sinclair
DINO
$16.3B
$14K 0.01%
+500
New +$14.6K
DLX icon
1766
Deluxe
DLX
$1.12B
$14K 0.01%
+200
New +$14.6K
EBF icon
1767
Ennis
EBF
$560M
$14K 0.01%
827
+463
+127% +$7.7K
LBTYK icon
1768
Liberty Global Class C
LBTYK
$3.48B
$14K 0.01%
400
-900
-69% -$31K
MATW icon
1769
Matthews International
MATW
$726M
$14K 0.01%
212
-388
-65% -$26.9K
MIDD icon
1770
Middleby
MIDD
$5.29B
$14K 0.01%
+100
New +$13.6K
NCLH icon
1771
Norwegian Cruise Line
NCLH
$8.93B
$14K 0.01%
+283
New +$13.7K
NL icon
1772
NLI Holdings
NL
$320M
$14K 0.01%
2,206
-8,555
-80% -$57.8K
OII icon
1773
Oceaneering
OII
$5.11B
$14K 0.01%
502
-3,198
-86% -$87.4K
PBT
1774
Permian Basin Royalty Trust
PBT
$1.54B
$14K 0.01%
+1,491
New +$13.3K
PLSE icon
1775
Pulse Biosciences
PLSE
$3.2B
$14K 0.01%
+701
New +$9.54K

Similar funds

Acrospire Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Acrospire Investment Management held 2,761 positions worth $121M, down 50% from $243M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.

Acrospire Investment Management withdrew a net $128M in Q1 2017, closing 547 positions and reducing 1,242 holdings. Its most notable exit was Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island), an estimated $595K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Acrospire Investment Management opened a new position in ScottsMiracle-Gro worth $149K.

  • Acrospire Investment Management's largest Q1 2017 buy was ScottsMiracle-Gro: 1,600 shares worth $149K.
  • Acrospire Investment Management added most to Navios Maritime Acquisition Corporation in Q1 2017, an estimated $796K increase.
  • Acrospire Investment Management's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $1.61M.
  • Acrospire Investment Management fully exited Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) in Q1 2017, selling an estimated $595K.
  • Acrospire Investment Management's ten largest holdings make up 3.4% of its $121M portfolio in Q1 2017.
  • Acrospire Investment Management opened 577 new positions and closed 547 in Q1 2017.
  • Acrospire Investment Management's portfolio value fell 50% quarter-over-quarter to $121M.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.